Back to News & Events

Dr. Carol A. Carter Elected to U.S. National Academy of Sciences

Congratulations to Dr. Carol A. Carter, SUNY Distinguished Professor in the Department of Microbiology and Immunology at the Stony Brook University Renaissance School of Medicine (RSOM), who was recently elected aa a member of the U.S. National Academy of Sciences (NAS.

The NAS is made up of the country’s leading researchers, who are elected in recognition of their distinguished and continuing achievements in original research. Election is considered one of the highest honors that a scientist can receive.

Dr. Carter is best known as an early pioneer in HIV research. At the onset of the AIDS pandemic, she advanced understanding of the viral-encoded protease and purified the viral capsid protein for structural and biochemical studies. She has also conducted research on Epstein-Barr Virus (EBV) and Severe Acute Respiratory Syndrome Coronavirus Virus-2 (SARS CoV-2), pathogens causing organ transplant rejection and COVID-19, respectively.

The Center for Biotechnology has had supported Dr. Carter’s interests in exploring the potential commercial applications of her research through our NIH-REACH program and Long Island Bioscience Hub (LIBH).

Read more about Dr. Carter’s work and her recent nomination here.

Related Stories

WP_Query Object
(
    [query] => Array
        (
            [post_type] => post
            [posts_per_page] => 3
            [post_status] => publish
            [orderby] => rand
        )

    [query_vars] => Array
        (
            [post_type] => post
            [posts_per_page] => 3
            [post_status] => publish
            [orderby] => rand
            [error] => 
            [m] => 
            [p] => 0
            [post_parent] => 
            [subpost] => 
            [subpost_id] => 
            [attachment] => 
            [attachment_id] => 0
            [name] => 
            [pagename] => 
            [page_id] => 0
            [second] => 
            [minute] => 
            [hour] => 
            [day] => 0
            [monthnum] => 0
            [year] => 0
            [w] => 0
            [category_name] => 
            [tag] => 
            [cat] => 
            [tag_id] => 
            [author] => 
            [author_name] => 
            [feed] => 
            [tb] => 
            [paged] => 0
            [meta_key] => 
            [meta_value] => 
            [preview] => 
            [s] => 
            [sentence] => 
            [title] => 
            [fields] => 
            [menu_order] => 
            [embed] => 
            [category__in] => Array
                (
                )

            [category__not_in] => Array
                (
                )

            [category__and] => Array
                (
                )

            [post__in] => Array
                (
                )

            [post__not_in] => Array
                (
                )

            [post_name__in] => Array
                (
                )

            [tag__in] => Array
                (
                )

            [tag__not_in] => Array
                (
                )

            [tag__and] => Array
                (
                )

            [tag_slug__in] => Array
                (
                )

            [tag_slug__and] => Array
                (
                )

            [post_parent__in] => Array
                (
                )

            [post_parent__not_in] => Array
                (
                )

            [author__in] => Array
                (
                )

            [author__not_in] => Array
                (
                )

            [search_columns] => Array
                (
                )

            [ignore_sticky_posts] => 
            [suppress_filters] => 
            [cache_results] => 1
            [update_post_term_cache] => 1
            [update_menu_item_cache] => 
            [lazy_load_term_meta] => 1
            [update_post_meta_cache] => 1
            [nopaging] => 
            [comments_per_page] => 50
            [no_found_rows] => 
            [order] => 
        )

    [tax_query] => WP_Tax_Query Object
        (
            [queries] => Array
                (
                )

            [relation] => AND
            [table_aliases:protected] => Array
                (
                )

            [queried_terms] => Array
                (
                )

            [primary_table] => wp_posts
            [primary_id_column] => ID
        )

    [meta_query] => WP_Meta_Query Object
        (
            [queries] => Array
                (
                )

            [relation] => 
            [meta_table] => 
            [meta_id_column] => 
            [primary_table] => 
            [primary_id_column] => 
            [table_aliases:protected] => Array
                (
                )

            [clauses:protected] => Array
                (
                )

            [has_or_relation:protected] => 
        )

    [date_query] => 
    [request] => SELECT SQL_CALC_FOUND_ROWS  wp_posts.ID
					 FROM wp_posts 
					 WHERE 1=1  AND wp_posts.post_type = 'post' AND ((wp_posts.post_status = 'publish'))
					 
					 ORDER BY RAND()
					 LIMIT 0, 3
    [posts] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 4439
                    [post_author] => 3
                    [post_date] => 2024-07-30 15:29:07
                    [post_date_gmt] => 2024-07-30 19:29:07
                    [post_content] => 

CFB Client, IAMBIC has been awarded approximately $1M in grant funding from the National Science Foundation Small Business Innovation Research program. IAMBIC is an innovative shoe company disrupting the centuries-old footwear industry with their sizeless, precision-fit footwear driven by proprietary AI algorithms. This substantial funding from NSF enables IAMBIC to scale its cutting-edge precision-fit shoe design and manufacturing.

The Center for Biotechnology and its accelerator programs have been instrumental in assisting IAMBIC with their SBIR pursuits and commercialization development.

Read more about IAMBIC and their recent funding here.

[post_title] => IAMBIC Receives $1 Million NSF SBIR Phase II Grant [post_excerpt] => This substantial funding from NSF enables IAMBIC to scale its operations. [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => iambic-receives-1-million-nsf-sbir-phase-ii-grant [to_ping] => [pinged] => [post_modified] => 2024-08-09 15:38:43 [post_modified_gmt] => 2024-08-09 19:38:43 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=4439 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [1] => WP_Post Object ( [ID] => 4272 [post_author] => 4 [post_date] => 2023-08-28 13:39:39 [post_date_gmt] => 2023-08-28 17:39:39 [post_content] =>

The Long Island BioMentor Initiative (LIBMI), created and managed by the Center for Biotechnology, is excited to welcome two new mentors, Dr. Annie Rohan, PhD, RN, FAANP, FAAN and Mike Horan, MBA.

Dr. Annie Rohan is currently Dean of the Henry P. Becton School Nursing and Allied Health at Fairleigh Dickinson University. Dr. Rohan is a dual-certified Nurse Practitioner whose academic achievements rest on the foundation of a 25-year clinical career caring for critically and chronically ill infants and children, and highest-risk families. To support diversification of the healthcare workforce, she has procured over $10-million in federal funding to support the education of underrepresented and disadvantaged students into the allied health and nursing professions. Dr. Rohan is currently Associate Editor for MCN: The American Journal of Maternal-Child Nursing, and has been honored with Fellowship in both the American Academy of Nurse Practitioners (FAANP) and American Academy of Nursing (FAAN).

Mike Horan, MBA is a Product Development, Engineering, and Operations Executive. He is an accomplished engineering and technology business leader with over 30 years of experience in product development. At Zebra Technologies, he currently serves as the Sr. Director of Global Quality overseeing quality for their product and solutions portfolio, supply chain and QMS. Mike has experience in Strategic & Portfolio Planning, Engineering Leadership, Program Management, Supply Chain, Manufacturing and Operations —all in a global environment. He is a highly motivational leader with experience in building high-performing teams.

The LIBM brings highly qualified volunteer mentors together with motivated, early-stage bioentrepreneurs to provide actionable guidance and support as they advance their business strategy. The initiative was developed in an alliance with MIT’s successful Venture Mentor Service and employs a team mentoring approach which is guided by a statement of principles to ensure confidentiality and a conflict free environment.

To learn more about the program or get involved, visit the LIBMI website or contact Ashley Abid, LIBMI Operations Manger (ashley.abid@stonybrook.edu)

[post_title] => Long Island BioMentor Initiative Welcomes New Mentors [post_excerpt] => Dr. Anne Rohan and Mr. Mike Horan have joined the esteem rosters of mentors among the Long Island BioMentor Initiative. [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => new-mentors-libmi-0823 [to_ping] => [pinged] => [post_modified] => 2024-08-22 11:37:59 [post_modified_gmt] => 2024-08-22 15:37:59 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=4272 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [2] => WP_Post Object ( [ID] => 3048 [post_author] => 3 [post_date] => 2018-08-23 19:48:21 [post_date_gmt] => 2018-08-23 19:48:21 [post_content] => Two specific funding programs have been designed to help faculty, physicians, surgeons, medical fellows, and post-docs develop their academic innovations toward commercial goals: Feasibility - up $50k/12 months (director costs) and Proof of Concept- up to $100k/12 months (direct cost) . Full details and application materials can be found here. Faculty members, physicians, post-doctoral associates, and BEIRs who are considering the submission of an application are strongly encouraged to discuss the proposal with Anton Xavier (anton.xavier@stonybrook.edu); William Hanes (william.hanes@stonybrook.edu) and/or Emily Kao (Emily.Kao@stonybrook.edu) at the LIBH prior to writing a full proposal.. Deadline for submission is September 19th, 2018. All proposal should be submitted through the online portal. Please note an approval from your Sponsored Programs Office is NOT required prior to the submission but will be required if the project is selected for NIH secondary review. Eligible applicants will be notified if their application is selected to move forward. The LIBH is supported by the National Institutes of Health REACH initiative (Research Evaluation and Commercialization Hub), our four partner institutions, The Research Foundation for SUNY, and Empire State Development. [post_title] => Long Island Bioscience Hub (LIBH) Technology Development RFP [post_excerpt] => Proposals for the 7th round of the Long Island Bioscience Hub (LIBH) Technology Development Funding are now being accepted with the deadline of September 19th, 2018. [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => long-island-bioscience-hub-libh-technology-development-rfp [to_ping] => [pinged] => [post_modified] => 2018-08-23 19:48:21 [post_modified_gmt] => 2018-08-23 19:48:21 [post_content_filtered] => [post_parent] => 0 [guid] => http://centerforbiotechnology.org/?p=3048 [menu_order] => 113 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [3] => WP_Post Object ( [ID] => 2180 [post_author] => 3 [post_date] => 2016-05-03 18:24:23 [post_date_gmt] => 2016-05-03 18:24:23 [post_content] => The Center for Biotechnology has announced the recipients of the 2016-2017 Applied Research & Development (ARAD) awards. The ARAD Program is designed to help bridge the gap between the early-stage technology discovery and development capabilities of the academic community and the later-stage commercial development interests of the bioscience industry. The program currently provides matching funds on a competitive basis to support collaborations between Stony Brook University faculty and NY State corporate partners in all areas of medical biotechnology. The primary interest is in supporting development of technologies that will help companies hit commercially relevant milestones, and that have the potential to positively impact the New York State economy. The projects funded include:
  • ICU Temporary Pacemaker - Dr. Wei Lin and Avery Biomedical Device, Inc.
  • Novel Synergistic and Pleiotropic Skin Brightening Agents - Dr. Sanford Simon and Biocogent, LLC
  • Continued In vivo Testing of Vaccine Candidates - Dr. Eckard Wimmer and Cogadenix, Inc.
  • Advanced Fistula-in-Ano Treatment Device - Dr. Tom Zimmerman and Pepper5, Inc.
  • Development of Nanoemulsion-PUFA-taxoids as Tumor-Targeted Chemotherapeutics - Dr. Iwao Ojima and TargaGenix, Inc.
  • Initial Pre-Clinical Safety Assessment of TRB-N0224 - Dr. Lorne Golub and Traverse Biosciences, Inc.
  • Evaluation of a Continuous Visible Light Disinfection System's Ability to Reduce Bioburden and Subsequently the Incidence of Infections and Colonizations in an Active Patient Area - Dr. Annie Rohan and Vital Vio, Inc.
More information about the Applied Research & Development (ARAD) program, as well as all Center for Biotechnology Technology Development programs can be found here. [post_title] => Applied Research and Development Awards Announced [post_excerpt] => The Center for Biotechnology has announced the recipients of the 2016-2017 Applied Research & Development (ARAD) awards. Matching funds have been awarded to seven projects in support of collaborations between Stony Brook University faculty and NY State corporate partners in all areas of medical biotechnology. [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => applied-research-and-development-awards-announced [to_ping] => [pinged] => [post_modified] => 2016-05-06 18:19:05 [post_modified_gmt] => 2016-05-06 18:19:05 [post_content_filtered] => [post_parent] => 0 [guid] => http://centerforbiotechnology.org/?p=2180 [menu_order] => 183 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) ) [post_count] => 4 [current_post] => -1 [before_loop] => 1 [in_the_loop] => [post] => WP_Post Object ( [ID] => 4439 [post_author] => 3 [post_date] => 2024-07-30 15:29:07 [post_date_gmt] => 2024-07-30 19:29:07 [post_content] =>

CFB Client, IAMBIC has been awarded approximately $1M in grant funding from the National Science Foundation Small Business Innovation Research program. IAMBIC is an innovative shoe company disrupting the centuries-old footwear industry with their sizeless, precision-fit footwear driven by proprietary AI algorithms. This substantial funding from NSF enables IAMBIC to scale its cutting-edge precision-fit shoe design and manufacturing.

The Center for Biotechnology and its accelerator programs have been instrumental in assisting IAMBIC with their SBIR pursuits and commercialization development.

Read more about IAMBIC and their recent funding here.

[post_title] => IAMBIC Receives $1 Million NSF SBIR Phase II Grant [post_excerpt] => This substantial funding from NSF enables IAMBIC to scale its operations. [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => iambic-receives-1-million-nsf-sbir-phase-ii-grant [to_ping] => [pinged] => [post_modified] => 2024-08-09 15:38:43 [post_modified_gmt] => 2024-08-09 19:38:43 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=4439 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [comment_count] => 0 [current_comment] => -1 [found_posts] => 260 [max_num_pages] => 87 [max_num_comment_pages] => 0 [is_single] => [is_preview] => [is_page] => [is_archive] => [is_date] => [is_year] => [is_month] => [is_day] => [is_time] => [is_author] => [is_category] => [is_tag] => [is_tax] => [is_search] => [is_feed] => [is_comment_feed] => [is_trackback] => [is_home] => 1 [is_privacy_policy] => [is_404] => [is_embed] => [is_paged] => [is_admin] => [is_attachment] => [is_singular] => [is_robots] => [is_favicon] => [is_posts_page] => [is_post_type_archive] => [query_vars_hash:WP_Query:private] => 325c4f9f1aebaa5ec90666fa54175ba0 [query_vars_changed:WP_Query:private] => [thumbnails_cached] => [allow_query_attachment_by_filename:protected] => [stopwords:WP_Query:private] => [compat_fields:WP_Query:private] => Array ( [0] => query_vars_hash [1] => query_vars_changed ) [compat_methods:WP_Query:private] => Array ( [0] => init_query_flags [1] => parse_tax_query ) )

IAMBIC Receives $1 Million NSF SBIR Phase II Grant

More Information

Long Island BioMentor Initiative Welcomes New Mentors

More Information

Long Island Bioscience Hub (LIBH) Technology Development RFP

More Information

Applied Research and Development Awards Announced

More Information